JP2001517456A - アルツハイマー病の診断試験 - Google Patents

アルツハイマー病の診断試験

Info

Publication number
JP2001517456A
JP2001517456A JP2000512983A JP2000512983A JP2001517456A JP 2001517456 A JP2001517456 A JP 2001517456A JP 2000512983 A JP2000512983 A JP 2000512983A JP 2000512983 A JP2000512983 A JP 2000512983A JP 2001517456 A JP2001517456 A JP 2001517456A
Authority
JP
Japan
Prior art keywords
ache
glycosylation pattern
isoform
ratio
wga
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000512983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001517456A5 (cg-RX-API-DMAC7.html
Inventor
デビッド ヘンリー スモール
ハーヴィエ サエツ−ヴァーレイロ
ギアン スベルナ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of JP2001517456A publication Critical patent/JP2001517456A/ja
Publication of JP2001517456A5 publication Critical patent/JP2001517456A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/827—Actinoplanes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2000512983A 1997-09-24 1998-09-24 アルツハイマー病の診断試験 Pending JP2001517456A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU9432 1989-01-09
AUPO9432A AUPO943297A0 (en) 1997-09-24 1997-09-24 Diagnostic test for alzheimer's disease
PCT/AU1998/000809 WO1999015695A1 (en) 1997-09-24 1998-09-24 Diagnostic test for alzheimer's disease

Publications (2)

Publication Number Publication Date
JP2001517456A true JP2001517456A (ja) 2001-10-09
JP2001517456A5 JP2001517456A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=3803714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000512983A Pending JP2001517456A (ja) 1997-09-24 1998-09-24 アルツハイマー病の診断試験

Country Status (11)

Country Link
US (1) US6461831B1 (cg-RX-API-DMAC7.html)
EP (1) EP1017845B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001517456A (cg-RX-API-DMAC7.html)
AT (1) ATE323781T1 (cg-RX-API-DMAC7.html)
AU (1) AUPO943297A0 (cg-RX-API-DMAC7.html)
BR (1) BR9813015A (cg-RX-API-DMAC7.html)
CA (1) CA2304949A1 (cg-RX-API-DMAC7.html)
DE (1) DE69834263D1 (cg-RX-API-DMAC7.html)
HU (1) HUP0003684A3 (cg-RX-API-DMAC7.html)
IL (1) IL135211A0 (cg-RX-API-DMAC7.html)
WO (1) WO1999015695A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130225A0 (en) * 1999-05-31 2000-06-01 Yissum Res Dev Co Novel uses of antibodies against ache and peptides thereof
US20020150878A1 (en) * 2001-01-23 2002-10-17 Small David Henry Method for the diagnosis of Alzheimer's Disease and other prion related disorders
WO2004066808A2 (en) * 2002-12-20 2004-08-12 Momenta Pharmaceuticals, Inc. Glycan markers for diagnosing and monitoring disease
GB2404734A (en) * 2003-08-05 2005-02-09 Secr Defence A method of screening a sample for abnormally glycosylated and/or expressed proteins
US7598049B2 (en) * 2003-11-19 2009-10-06 Satoris, Inc. Methods for diagnosis of Alzheimer's Disease in blood samples
US20060094064A1 (en) * 2003-11-19 2006-05-04 Sandip Ray Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
US20050272643A1 (en) * 2004-06-08 2005-12-08 Windber Research Institute Removal of serum albumin from human serum or plasma
US7851172B2 (en) * 2006-07-25 2010-12-14 University Of Kentucky Research Foundation Biomarkers of mild cognitive impairment and alzheimer's disease
US20100124756A1 (en) * 2008-10-10 2010-05-20 Sandip Ray Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids
US20110237537A1 (en) * 2009-05-29 2011-09-29 Lombard Jay L Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
US9493834B2 (en) 2009-07-29 2016-11-15 Pharnext Method for detecting a panel of biomarkers
US20110202284A1 (en) * 2010-02-10 2011-08-18 Mcreynolds Cristopher Novel groups of biomarkers for diagnosing alzheimer's disease
ES2395063B1 (es) * 2011-03-04 2014-02-07 Universidad Miguel Hernández De Elche Método para determinar la enfermedad de Alzheimer mediante la detección de glicoproteínas portadoras del glicoepítopo HNK-1
EP3255435A1 (en) 2012-04-13 2017-12-13 Oasis Diagnostics Corporation Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595883A (en) * 1990-06-01 1997-01-21 E. R. Squibb & Sons, Inc. Method of diagnosing alzheimer's disease by measuring acetylcholinesterase activity in ocular fluid
CA2048700A1 (en) 1990-09-04 1992-03-05 Dasakumar S. Navaratnam Method for diagnosing senile dementia of the alzheimer type
US5200324A (en) * 1990-09-04 1993-04-06 E. R. Squibb & Sons, Inc. Method of diagnosing senile dementia of the Alzheimer type

Also Published As

Publication number Publication date
HUP0003684A3 (en) 2003-04-28
BR9813015A (pt) 2000-08-15
CA2304949A1 (en) 1999-04-01
DE69834263D1 (de) 2006-05-24
ATE323781T1 (de) 2006-05-15
EP1017845A1 (en) 2000-07-12
AUPO943297A0 (en) 1997-10-16
US6461831B1 (en) 2002-10-08
HUP0003684A2 (hu) 2001-02-28
IL135211A0 (en) 2001-05-20
EP1017845B1 (en) 2006-04-19
EP1017845A4 (en) 2003-07-02
WO1999015695A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
Boza-Serrano et al. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
Dasouki et al. Pompe disease: literature review and case series
Paragh et al. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia
US6461831B1 (en) Diagnostic test for alzheimer's disease
Selcen et al. Dok‐7 myasthenia: phenotypic and molecular genetic studies in 16 patients
Sberna et al. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C‐terminal fragment (CT100) of the β‐amyloid protein precursor of Alzheimer's disease
US5270165A (en) Method of diagnosis of amyloidoses
US20020022242A1 (en) Diagnostic test for alzheimer's disease
Lee et al. Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy
JP5668201B2 (ja) スクリーニング方法
EP0564946A1 (en) A diagnostic assay for alzheimer's disease based on the proteolysis of the amyloid precursor protein
EP2813853B1 (en) Use of an internal standard in a diagnostic method for Alzheimer's disease
KR102144047B1 (ko) 퇴행성 신경질환 진단용 조성물
US20090023145A1 (en) Methods of diagnosing or prognosing Alzheimer's disease
US5213962A (en) Purification, detection and methods of use of protease Nexin-2
US5506097A (en) Method for inhibiting β-protein enzymatic activity
Sirin et al. The relationship of early-and late-onset Alzheimer’s disease genes with COVID-19
EP0623146A1 (en) COMPOUNDS AND METHODS FOR INHIBITING $g(b)-PROTEIN FUNCTION
Silveyra et al. Altered glycosylation of acetylcholinesterase in Creutzfeldt–Jakob disease
AU744215B2 (en) Diagnostic test for Alzheimer's disease
Kizuka Glycans and Alzheimer’s Disease
EP1451360A2 (en) Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
MXPA00002858A (en) Diagnostic test for alzheimer's disease
CZ20001053A3 (cs) Diagnostický test na Alzheimerovu chorobu
EP4071165A1 (en) A new non-aggregative splicing isoform of human tau is decreased in alzheimer s disease

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040728

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20040728

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040728

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050921

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050921

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080716

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081210